Prof. John B. Haanen - Why MAP 2020 Virtual Congress is a must-attend congress
Prof. John B. Haanen, MAP 2020 Virtual Scientific Co-Chair, illustrates MAP 2020 Virtual Congress educational objectives and why this represents an event not to be missed.
https://www.esmo.org/meetings/map-virtual-2020
Produced by the European Society for Medical Oncology http://www.esmo.org
Видео Prof. John B. Haanen - Why MAP 2020 Virtual Congress is a must-attend congress канала European Society for Medical Oncology (ESMO)
https://www.esmo.org/meetings/map-virtual-2020
Produced by the European Society for Medical Oncology http://www.esmo.org
Видео Prof. John B. Haanen - Why MAP 2020 Virtual Congress is a must-attend congress канала European Society for Medical Oncology (ESMO)
Показать
Комментарии отсутствуют
Информация о видео
2 октября 2020 г. 13:35:43
00:02:25
Другие видео канала
Expert Report on latest data in the management of metastatic prostate cancer from ASCO 2022
OncologyPRO, a 360 research solution designed around you
AACR 2023 highlights on advances in the treatment of resected high-risk melanoma with Jeffrey Weber
Essentials in bioinformatics and systems biology for oncologists
ESMO Clinical Unit Visit
Supportive care in the context of precision cancer medicine
Gender Medicine in Oncology - An ESMO Initiative
#ESMO21 Highlights on a phase I of dual RAF/MEK inhibitor + FAK inhibitor in ovarian cancer (FRAME)
Expert Video Report on therapeutic advances in NSCLC from 2021 ASCO Annual Meeting
ESMO Recommendations for Use of Tumour Multigene NGS in Metastatic Cancers
How Can Cancer Affect Bone Health
Personalised medicine: The impact in elderly patients with cancer
#ESMO23 Head and neck cancer Track highlights with Chair Paolo Bossi
#ESMO21 Expert Video Report on colorectal cancer
Expert Report on novelties in the management of gynaecological malignancies from ASCO 2022
#ESMO23 Genitourinary tumours (non-prostate) Track highlights with Chair Michiel van der Heijden
How to select patients with localised soft tissue sarcoma for neoadjuvant/adjuvant chemotherapy?
ESMO OncologyPRO - Intro by Prof. A. MATIKAS
Expert Commentary: Melanoma, Breast and Gynaecological Cancers at ESMO Congress 2021
Silke Gillessen: Translational research to clinical practice, #ESMO23 to cater for every oncologist
ESMO 2019 Daily Reporter - Editor's Picks: Ovarian cancer